Search results
Is Eli Lilly Stock A Buy After Weight-Loss Drug Crushes Quarterly Sales Forecasts?
Investor's Business Daily· 1 week agoLilly just acquired Versanis Bio, which has a drug that could improve fat loss while limiting muscle...
Zacks Industry Outlook Highlights Eli Lilly, Novo Nordisk, Merck and AbbVie
Zacks via Yahoo Finance· 2 weeks agoLilly's new tirzepatide medicines, diabetes drug Mounjaro and newly launched weight loss medicine,...
Rybelsus vs. Ozempic: How These Drugs Compare
Healthline· 1 week agoRybelsus (semaglutide) and Ozempic (semaglutide) are prescription drugs used to treat type 2 diabetes. Rybelsus comes as an oral tablet, while Ozempic comes ...
Fred L. Goldenberg: Medicare 2025 starting to bloom
Traverse City Record-Eagle· 3 days agoOver the last few weeks, I’ve been involved in several meetings, both in-person and online, regarding anticipated changes to Medicare and supplemental programs ...
Board trying to lower drug costs urges Marylanders to help ‘fill in’ info gaps
Maryland Matters via Yahoo News· 1 week agoThe Prescription Drug Affordability Board is seeking feedback from patients, physicians and manufactures to provide context and first-hand ...
This Is What Whales Are Betting On Eli Lilly and Co - Eli Lilly and Co (NYSE:LLY)
Benzinga· 2 days agoLilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for diabetes;
Lilly Is Expensive, But Priced for Explosive Growth: How to Trade It
TheStreet.com· 1 week agoOn Tuesday morning, pharmaceutical giant Eli Lilly released the firm's first quarter financial...
Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims
Zacks via Yahoo Finance· 5 days ago(See the last pharma stock roundup here: MRK, SNY, AZN, NVS’ Q1 Results, Pipeline & Regulatory...
May 1, 2024, Letters to the Editor
The Record-Courier· 1 week agoDespite public objections, the Forest Service has now agreed to a new lease adding another ½ mile of lakefront, doubling the lease of public lands on...
